Bicycle Therapeutics (NASDAQ: BCYC) COO reports initial share, RSU and option holdings

Rhea-AI Filing Summary

Bicycle Therapeutics plc Chief Operating Officer Jennifer Scott Perry has filed an initial ownership report showing her equity position in the company. The filing lists direct ownership of 93,872 Ordinary Shares, which includes 84,697 restricted share units that vest in scheduled quarterly installments beginning on April 2, 2026 and April 3, 2026, and in larger tranches from January 2, 2027 onward.

In addition to common shares and RSUs, Perry holds multiple employee stock options over Ordinary Shares with different exercise prices and long-dated expirations. Examples include options over 20,000 underlying Ordinary Shares at an exercise price of $26.4500 expiring on September 1, 2032, and options over 100,000 underlying Ordinary Shares at an exercise price of $7.0800 expiring on January 2, 2036. The vesting footnotes show these options generally vest one-fourth on a specified initial date, with the remaining shares vesting in equal monthly installments over 36 months.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Perry Jennifer Scott

(Last) (First) (Middle)

C/O BICYCLE THERAPEUTICS PLC

BLOCKS A & B, PORTWAY BUILDING

(Street)

CAMBRIDGE CB21 6GS

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026

3. Issuer Name and Ticker or Trading Symbol
BICYCLE THERAPEUTICS PLC [ BCYC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)	93,872(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(3)	09/01/2032	Ordinary Shares	20,000	$26.45	D
Employee Stock Option (right to buy)	(4)	01/03/2033	Ordinary Shares	3,576	$29.6	D
Employee Stock Option (right to buy)	(5)	03/13/2033	Ordinary Shares	30,000	$20.02	D
Employee Stock Option (right to buy)	(6)	01/02/2034	Ordinary Shares	31,000	$18.08	D
Employee Stock Option (right to buy)	(7)	07/16/2034	Ordinary Shares	58,000	$22.6	D
Employee Stock Option (right to buy)	(8)	01/02/2035	Ordinary Shares	87,000	$14	D
Employee Stock Option (right to buy)	(9)	01/02/2036	Ordinary Shares	100,000	$7.08	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which represents one ordinary share.

2. Includes 84,697 restricted share units ("RSUs"). 447 RSUs vest in four equal quarterly installments commencing on April 3, 2026; 8,000 RSUs vest in eight equal quarterly installments commencing on April 2, 2026; 26,250 RSUs vest in twelve equal quarterly installments commencing on April 2, 2026; and 50,000 RSUs vest one-fourth (1/4) on January 2, 2027 and the remaining RSUs vest in twelve equal quarterly installments thereafter.

3. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on August 24, 2023 and the remaining shares vested or vest in 36 equal monthly installments thereafter.

4. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares vested or vest in 36 equal monthly installments thereafter.

5. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on March 13, 2024 and the remaining shares vested or vest in 36 equal monthly installments thereafter.

6. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares vested or vest in 36 equal monthly installments thereafter.

7. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on July 16, 2025 and the remaining shares vested or vest in 36 equal monthly installments thereafter.

8. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares vested or vest in 36 equal monthly installments thereafter.

9. This option vests with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares vest in 36 equal monthly installments thereafter.

	/s/ Travis Thompson, Attorney-in-Fact	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing by BCYC COO Jennifer Scott Perry show?

The Form 3 shows Jennifer Scott Perry’s existing equity holdings in Bicycle Therapeutics. She directly owns 93,872 Ordinary Shares, including 84,697 restricted share units, plus several employee stock option grants with specified exercise prices and multi‑year vesting and expiration schedules.

How many Bicycle Therapeutics (BCYC) restricted share units does Jennifer Scott Perry hold?

Jennifer Scott Perry holds 84,697 restricted share units in Bicycle Therapeutics. These RSUs vest over time through multiple schedules, beginning with quarterly vesting from April 2 and April 3, 2026, and a larger grant starting January 2, 2027 with subsequent quarterly vesting.

What stock options in BCYC are reported for COO Jennifer Scott Perry?

The filing lists several employee stock options over Ordinary Shares for Jennifer Scott Perry. Examples include options over 20,000 shares at an exercise price of $26.4500 expiring September 1, 2032, and options over 100,000 shares at $7.0800 expiring January 2, 2036.

How do Jennifer Scott Perry’s Bicycle Therapeutics stock options vest over time?

The options generally vest one‑fourth of the total shares on an initial vesting date, with remaining shares vesting in 36 equal monthly installments. Footnotes specify dates such as August 24, 2023, January 3, 2024, March 13, 2024, and January 2, 2025 as initial vesting milestones.

Does the BCYC Form 3 indicate any stock purchases or sales by Jennifer Scott Perry?

The Form 3 functions as an initial ownership report and lists holdings rather than new transactions. It shows direct ownership of Ordinary Shares, restricted share units, and outstanding employee stock options, without indicating any open‑market purchases or sales in this filing.

Are Bicycle Therapeutics (BCYC) Ordinary Shares represented by ADSs for Jennifer Scott Perry’s holdings?

Yes. A footnote explains that the Ordinary Shares may be represented by American Depositary Shares, with each ADS corresponding to one Ordinary Share. This applies to the Ordinary Share and option positions reported for Jennifer Scott Perry.